Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability

Surade, Sachin, Blundell, Tom L.·2012·Chemistry & Biology
DOI 10.1016/j.chembiol.2011.12.013

Cited by (234)

Items 101–200 of 234

  1. Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer
    Jianying Jin, Qunyi Guo, Jingjing Xie, Dan Jin, Yanan Zhu · 2019 · Pathology & Oncology Research
  2. Development of Inhibitors of Plasmodium falciparum Apical Membrane Antigen 1 Based on Fragment Screening
    San Sui Lim, Cael O. Debono, Christopher A. MacRaild, Indu R. Chandrashekaran, Olan Dolezal, Robin F. Anders, Jamie S. Simpson, Martin J. Scanlon, Shane M. Devine, Peter J. Scammells et al. · 2013 · Australian Journal of Chemistry
  3. Peptide ligands targeting the vesicular stomatitis virus G (VSV‐G) protein for the affinity purification of lentivirus particles
    Eduardo Barbieri, Gina N. Mollica, Brandyn Moore, Sobhana Alekhya Sripada, Shriarjun Shastry, Ryan Kilgore, Casee M. Loudermilk, Zachary H. Whitacre, Katie M. Kilgour, Elena Wüstenhagen et al. · 2023 · Biotechnology and Bioengineering
  4. PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK
    Tao Lu, Yanmei Zou, Guogang Xu, Jane A. Potter, Garry L. Taylor, Qiuhong Duan, Qin Yang, Huihua Xiong, Hong Qiu, Dawei Ye et al. · 2016 · Oncotarget
  5. Screening and Evaluation of Small Organic Molecules as ClpB Inhibitors and Potential Antimicrobials
    Ianire Martín, Jarl Underhaug, Garbiñe Celaya, Fernando Moro, Knut Teigen, Aurora Martı́nez, Arturo Muga · 2013 · Journal of Medicinal Chemistry
  6. Innovative Computer-Aided Methods for the Discovery of New Kinase Ligands
    Areej Abuhammad, Mutasem O. Taha · 2016 · Future Medicinal Chemistry
  7. The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target
    Michael F. Sharp, Rohan Bythell‐Douglas, Andrew J. Deans, Wayne Crismani · 2021 · Molecular Cell
  8. Comprehensive Insights into Natural Bioactive Compounds: From Chemical Diversity and Mechanisms to Biotechnological Innovations and Applications
    Sajid Ali, Atif Ali Khan Khalil, Muhammad Saeed Akhtar, Adnan Amin, Wajid Zaman · 2025 · ChemistryOpen
  9. SHREC 2022: Protein–ligand binding site recognition
    Luca Gagliardi, Andrea Raffo, Ulderico Fugacci, Silvia Biasotti, Walter Rocchia, Hao Ming Huang, Boulbaba Ben Amor, Yi Fang, Yuanyuan Zhang, Xiao Wang et al. · 2022 · Computers & Graphics
  10. Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery
    Daniela Trisciuzzi, Bruno O. Villoutreix, Lydia Siragusa, Massimo Baroni, Gabriele Cruciani, Orazio Nicolotti · 2023 · Expert Opinion on Drug Discovery
  11. 3‐Substituted Indazoles as Configurationally Locked 4EGI‐1 Mimetics and Inhibitors of the eIF4E/eIF4G Interaction
    Revital Yefidoff‐Freedman, Ting Chen, Rupam Sahoo, Limo Chen, Gerhard Wagner, José A. Halperin, Bertal Huseyin Aktas, Michael Chorev · 2014 · ChemBioChem
  12. Engineering Archeal Surrogate Systems for the Development of Protein–Protein Interaction Inhibitors against Human RAD51
    Tommaso Moschetti, Timothy Sharpe, Gerhard W. Fischer, M. Marsh, Hong Kin Ng, Matthew Morgan, Duncan E. Scott, Tom L. Blundell, Ashok R. Venkitaraman, John Skidmore et al. · 2016 · Journal of Molecular Biology
  13. Vemurafenib in melanoma
    Heather May Shaw, Paul Nathan · 2013 · Expert Review of Anticancer Therapy
  14. Query-guided protein–protein interaction inhibitor discovery
    Sergio Celis, Fruzsina Hóbor, Thomas James, Gail J. Bartlett, Amaurys Ávila Ibarra, Deborah K. Shoemark, Zsófia Hegedüs, Kristina Hetherington, Derek N. Woolfson, Richard Barry Sessions et al. · 2021 · Chemical Science
  15. SiteFerret: Beyond Simple Pocket Identification in Proteins
    Luca Gagliardi, Walter Rocchia · 2023 · Journal of Chemical Theory and Computation
  16. The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
    Hayelom Berhe Dagnaw, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, Nir Qvit · 2024 · Pharmaceutics
  17. Structural and evolutionary analysis of Leishmania Alba proteins
    Kauê Santana da Costa, João Marcos Pereira Galúcio, Elvis Santos Leonardo, Guelber Cardoso, Elcio de Souza Leal, Guilherme Augusto Barros Conde, Jerônimo Lameira · 2017 · Molecular and Biochemical Parasitology
  18. Design of Drug‐Like Protein–Protein Interaction Stabilizers Guided By Chelation‐Controlled Bioactive Conformation Stabilization
    Francesco Bosica, Sebastian A. Andrei, João Filipe Neves, Peter Brandt, Anders Gunnarsson, Isabelle Landrieu, Christian Ottmann, Gavin O’Mahony · 2020 · Desy Publications Database (Deutsches Elektronen-Synchrotron DESY)
  19. Identification of the β-Lactamase Inhibitor Protein-II (BLIP-II) Interface Residues Essential for Binding Affinity and Specificity for Class A β-Lactamases
    Nicholas Gene Brown, Dar‐Chone Chow, Kevin E. Ruprecht, Timothy Gerald Palzkill · 2013 · Journal of Biological Chemistry
  20. Native Mass Spectrometry‐Guided Screening Identifies Hit Fragments for HOP‐HSP90 PPI Inhibition**
    Michaelone C. Vaaltyn, Maria Mateos‐Jimenez, Ronel Müller, C. Logan Mackay, Adrienne Lesley Edkins, David J. Clarke, Clinton G. L. Veale · 2022 · ChemBioChem
  21. Distinct Hybrid Hydrates of Paritaprevir: Combined Experimental and Computational Assessment of their Hydration–Dehydration Behavior and Implications for Regulatory Controls
    Richard S. Hong, Rajni M. Bhardwaj, Rodger F. Henry, Alessandra Mattei, Moiz Diwan, Albert Thomas, Gerald D. Danzer, Ahmad Y. Sheikh · 2021 · Crystal Growth & Design
  22. Why We Need to Implement Intramolecular Hydrogen-Bonding Considerations in Drug Discovery
    Giulia Caron, Giuseppe Ermondi · 2016 · Future Medicinal Chemistry
  23. Discovery of RNA‐Targeting Small Molecules: Challenges and Future Directions
    Zhengguo Cai, Hongli Ma, Fengcan Ye, Dingwei Lei, Zhenfeng Deng, Yongge Li, Ruichu Gu, Han Wen · 2025 · MedComm
  24. Protein-Protein Interactions: Structures and Druggability
    David Benjamin Ascher, Harry C. Jubb, Douglas E. V. Pires, Takashi Ochi, Alícia P. Higueruelo, Tom L. Blundell · 2015 · NATO science for peace and security series. A, Chemistry and biology
  25. Characterization of the Free State Ensemble of the CoRNR Box Motif by Molecular Dynamics Simulations
    Elio A. Cino, Wing‐Yiu Choy, Mikko Karttunen · 2016 · The Journal of Physical Chemistry B
  26. High-throughput platform for yeast morphological profiling predicts the targets of bioactive compounds
    Shinsuke Ohnuki, Itsuki Ogawa, Kaori Itto‐Nakama, Fachuang Lu, Ashish Ranjan, Mehdi Kabbage, Abraham Abera Gebre, Masao Yamashita, Sheena Claire Li, Yoko Yashiroda et al. · 2022 · npj Systems Biology and Applications
  27. Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets
    Anna Charalampidou, Thomas Nehls, Christian Meyners, Satish Gandhesiri, Sebastian J. Pomplun, Bradley L. Pentelute, Frederik Lermyte, Felix Hausch · 2024 · ACS Central Science
  28. The Medicinal Chemistry of Chalcones as Anti-Mycobacterium tuberculosis Agents
    Jean Leandro dos Santos, Cristhian N. Rodríguez-Silva, Igor Muccilo Prokopczyk · 2022 · Mini-Reviews in Medicinal Chemistry
  29. Fragment‐Based Protein–Protein Interaction Antagonists of a Viral Dimeric Protease
    Jonathan E. Gable, Gregory Lee, Timothy M. Acker, Kaitlin R. Hulce, Eric R. Gonzalez, Patrick Schweigler, Samu Melkko, Christopher J. Farady, Charles S. Craik · 2016 · ChemMedChem
  30. AgNPs and Ag/C225 Exert Anticancerous Effects via Cell Cycle Regulation and Cytotoxicity Enhancement
    Yan Zhang, Hong Lu, Dahai Yu, Di Zhao · 2017 · Journal of Nanomaterials
  31. Electron‐deficient p‐benzoyl‐ l ‐phenylalanine derivatives increase covalent chemical capture yields for protein–protein interactions
    Cassandra M. Joiner, Meghan E. Breen, Anna K. Mapp · 2019 · Protein Science
  32. High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
    Gregory B. Craven, Dominic P. Affron, Charlotte E. Allen, Stefan Matthies, Joe G. Greener, Rhodri M. L. Morgan, Edward W. Tate, Alan Armstrong, David J. Mann · 2018 · Angewandte Chemie
  33. Inhibition of Snail1-DNA-PKcs Protein-Protein Interface Sensitizes Cancer Cells and Inhibits Tumor Metastasis
    Ga-Young Kang, Bo‐Jeong Pyun, Haeng Ran Seo, Yeung Bae Jin, Hae‐June Lee, Yoon-Jin Lee, Yun-Sil Lee · 2013 · Journal of Biological Chemistry
  34. Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery
    Nana Du, Yijun Li, Qing Lou, Gong Zhang, Yangfeng Li, Yizhou Li · 2026 · Pharmaceutical Science Advances
  35. Computer-aided discovery of dual-target compounds for Alzheimer’s from ayurvedic medicinal plants
    Mohibullah Shah, Sadia Pervaiz, Iqra Ahmad, Shahid Habib Ansari, Valdir Ferreira de Paula, Sibtain Ahmed, Muhammed Umer Khan, Khaled Fahmi Fawy, Umar Nishan, Hanna Dib et al. · 2025 · PLoS ONE
  36. BcL-xL Conformational Changes upon Fragment Binding Revealed by NMR
    Clémentine Aguirre, Tim ten Brink, Olivier Walker, Florence Guillière, D. Davesne, Isabelle Krimm · 2013 · PLoS ONE
  37. Peptides Binding Cocaine: A Strategy to Design Biomimetic Receptors
    Germán Pérez · 2012 · Journal of Proteomics & Bioinformatics
  38. A native mass spectrometry platform identifies HOP inhibitors that modulate the HSP90–HOP protein–protein interaction
    Clinton G. L. Veale, Maria Mateos‐Jimenez, Michaelone C. Vaaltyn, Ronel Müller, Matodzi Makhubu, Mahama Alhassan, Beatriz G. de la Torre, Fernando Alberício, C. Logan Mackay, Adrienne Lesley Edkins et al. · 2021 · Chemical Communications
  39. A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53‐Mediated Apoptosis
    Misook Oh, Ji Hoon Lee, Heejo Moon, Yu-Jung Hyun, Hyun‐Suk Lim · 2015 · Angewandte Chemie
  40. Aberrant coordination geometries discovered in the most abundant metalloproteins
    Sen Yao, Robert M Flight, Eric Christian Rouchka, Hunter Moseley · 2017 · Proteins Structure Function and Bioinformatics
  41. Overview of Macrocycles in Clinical Development and Clinically Used
    Silvia Stotani, Fabrizio Giordanetto · 2017
  42. Targeting secondary protein complexes in drug discovery: studying the druggability and chemical biology of the HSP70/BAG1 complex
    Lindsay E. Evans, Keith Jones, Matthew D. Cheeseman · 2017 · Chemical Communications
  43. Small Glycols Discover Cryptic Pockets on Proteins for Fragment-Based Approaches
    Harsh Bansia, Pranjal Mahanta, Neela H. Yennawar, Suryanarayanarao Ramakumar · 2021 · Journal of Chemical Information and Modeling
  44. Mechanochemical Activation of Class-B G-Protein-Coupled Receptor upon Peptide–Ligand Binding
    Cristina Lo Giudice, Haonan Zhang, Beili Wu, David Alsteens · 2020 · Nano Letters
  45. A Novel Inhibitor of Mammalian Triosephosphate Isomerase Found by an In Silico Approach
    Lorraine Marsh, Kaushal Shah · 2014 · International Journal of Medicinal Chemistry
  46. Ligandability at the Membrane Interface of GPx4 Revealed through a Reverse Micelle Fragment Screening Platform
    Courtney L. Labrecque, Brian Fuglestad · 2024 · JACS Au
  47. Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease
    Xinrui Yuan, Hua Jiang, Denggang Fu, Aaron M. Robida, Krishani Kumari Rajanayake, Hebao Yuan, Bo Wen, Duxin Sun, Brennan T. Watch, Krishnapriya Chinnaswamy et al. · 2022 · Bioorganic & Medicinal Chemistry
  48. eQuant - A Server for Fast Protein Model Quality Assessment by Integrating High-Dimensional Data and Machine Learning
    Sebastian Bittrich, Florian Heinke, Dirk Labudde · 2016 · Communications in computer and information science
  49. Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors
    Xinrui Yuan, Hua Jiang, Denggang Fu, Jason C. Rech, Aaron M. Robida, Krishani Kumari Rajanayake, Hebao Yuan, Miao He, Bo Wen, Duxin Sun et al. · 2023 · ACS Pharmacology & Translational Science
  50. Binding pocket stabilization by high-throughput screening of yeast display libraries
    Jorge A. Lerma Romero, Christian Meyners, Andreas Christmann, Lisa M. Reinbold, Anna Charalampidou, Felix Hausch, Harald Kolmar · 2022 · Frontiers in Molecular Biosciences
  51. FDA/M-CERSI Co-Processed API Workshop Proceedings
    Luke Schenck, Paresma Patel, Ramesh K. Sood, Llorente R. Bonaga, Peter Capella, Olivier Dirat, Deniz Erdemir, Steven Ferguson, Cinzia Gazziola, Lindsey Saunders Gorka et al. · 2023 · Journal of Pharmaceutical Sciences
  52. Probing Protein Surfaces: QSAR Analysis with Helix Mimetics
    Valeria Azzarito, Philip R. Rowell, Anna Barnard, Thomas A. Edwards, Andrew Macdonald, Stuart L. Warriner, Andrew John Wilson · 2015 · ChemBioChem
  53. A mechanistic overview of herbal medicine and botanical compounds to target transcriptional factors in Breast cancer
    Yingke Zhao, Yue Liu · 2017 · Pharmacological Research
  54. Druggability of protein–protein interactions
    Véronique Hamon, Xavier Morelli · 2013
  55. Machine Learning Applications in Drug Discovery
    Sadettin Y. Ugurlu, David McDonald, Shan He · 2025 · French-Ukrainian Journal of Chemistry
  56. Ligandability Assessment of Human Glutathione Transferase M1-1 Using Pesticides as Chemical Probes
    Charoutioun S. Bodourian, Nirmal Poudel, Anastassios C. Papageorgiou, Mariana Antoniadi, Nikolaos Georgakis, Hiroshi Abe, Nikolaos E. Labrou · 2022 · International Journal of Molecular Sciences
  57. Design, synthesis and conformational analyses of bifacial benzamide based foldamers
    Silvia Rodriguez‐Marin, Natasha S. Murphy, Helena J. Shepherd, Andrew John Wilson · 2015 · RSC Advances
  58. Tiered analytics for purity assessment of macrocyclic peptides in drug discovery: Analytical consideration and method development
    Jingfang Cutrone, Xiaohua Stella Huang, Edward S. Kozlowski, Ye Bao, Yingzi Wang, Chris Poronsky, Dieter M. Drexler, Adrienne A. Tymiak · 2017 · Journal of Pharmaceutical and Biomedical Analysis
  59. Targeting the transmembrane domain 5 of latent membrane protein 1 using small molecule modulators
    Bo Zhang, Yibo Wang, Cong Lin, Hongyuan Li, Xiaojie Wang, Yinghua Peng, Konstantin S. Mineev, Andrew John Wilson, Hongshuang Wang, Xiaohui Wang · 2021 · European Journal of Medicinal Chemistry
  60. Lead Generation Based on Compound Collection Screening
    Dirk Weigelt, Ismet B. Dorange · 2016 · Methods and principles in medicinal chemistry
  61. Small-Molecule Inhibition of SOST Suppresses Breast Cancer Bone Metastasis
    Yousef Hamdan Khalil, Omar Salman Nassar · 2025 · Archive of International Journal of Cancer and Allied Science
  62. The effect of gem -difluorination on the conformation and properties of a model macrocyclic system
    Thomas J. Cogswell, Richard J. Lewis, Christian Sköld, Anneli Nordqvist, Marie M. Ahlqvist, Laurent Knerr · 2024 · Chemical Science
  63. Revealing Missing Protein–Ligand Interactions Using AlphaFold Predictions
    Nahuel Escobedo, Tadeo Enrique Saldaño, Juan Mac Donagh, Luciana Rodriguez Sawicki, Nicolás Palópoli, Sebastian Fernández-Alberti, Marı́a Silvina Fornasari, Gustavo D. Parisi · 2024 · Journal of Molecular Biology
  64. “Ligandability” of Drug Targets: Assessment of Chemical Tractability via Experimental and In Silico Approaches
    Udo Bauer, Alexander L. Breeze · 2016 · Methods and principles in medicinal chemistry
  65. Ghost interactions: revealing missing protein-ligand interactions using AlphaFold predictions
    Nahuel Escobedo, Tadeo Enrique Saldaño, Juan Mac Donagh, Luciana Rodriguez Sawicki, Nicolás Palópoli, Sebastian Fernández-Alberti, Marı́a Silvina Fornasari, Gustavo D. Parisi · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Saturation transfer difference (STD)-NMR spectroscopy in drug discovery: A comprehensive review on identified potential hits based on natural and synthetic scaffolds against therapeutic drug targets
    Salar Hafez Ghoran, Uzma Salar · 2025 · Bioorganic & Medicinal Chemistry
  67. Impact of Protein Conformational Diversity on Structure-Based Prediction of Druggability
    Ayse A. Bekar-Cesaretli, Shray Vats, Adrian Whitty, Dima Kozakov, Diane Joseph‐McCarthy, Sándor Vajda · 2025 · Journal of Chemical Information and Modeling
  68. Identification of Chemokine Ligands by Biochemical Fragmentation and Simulated Peptide Evolution
    Jens A. Fuchs, Cyrill Brunner, Philipp Schineis, Jan A. Hiss, Gisbert Schneider · 2019 · Angewandte Chemie International Edition
  69. Exploring the Antimicrobial Potential of 1,3,4-Oxadiazole Derivatives: Synthesis, Characterization, and Biological Evaluation
    S. A. Patel · 2024 · Russian Journal of General Chemistry
  70. Hydrogen/Deuterium Exchange and Protein Oxidative Footprinting with Mass Spectrometry Collectively Discriminate the Binding of Small-Molecule Therapeutics to Bcl-2
    Yan Sun, Damian J. Houde, Roxana E. Iacob, Jason Baird, Robert V. Swift, Michael Holliday, Xuyan Shi, Simone Sidoli, Michael D. Brenowitz · 2025 · Analytical Chemistry
  71. Statistical Profiling of One Promiscuous Protein Binding Site: Illustrated by Urokinase Catalytic Domain
    Natacha Cerisier, Leslie Regad, Dhoha Triki, Michel Petitjean, Delphine Flatters, Anne‐Claude Camproux · 2017 · Molecular Informatics
  72. Covalent fragment screening
    Amit Shraga, Efrat Resnick, Ronen Gabizon, Nir London · 2021 · Annual reports in medicinal chemistry
  73. Cyclophilin Succumbs to a Macrocyclic Chameleon
    B.C. Doak, Jan O. Kihlberg · 2018 · Journal of Medicinal Chemistry
  74. ZeroGEN: leveraging language models for zero-shot ligand design from protein sequences
    Yangyang Chen, Zixu Wang, Pengyong Li, Li Zeng, Xiangxiang Zeng, Lei Xu · 2025 · Bioinformatics
  75. Targeting protein–protein interactions with reversible covalent modalities: Non‐cysteine chemistries
    Ruchira Basu, Steven Fletcher · 2026 · British Journal of Pharmacology
  76. Spindle Assembly Checkpoint (SAC): More New Targets for Anti-Cancer Drug Therapies
    2014 · BENTHAM SCIENCE PUBLISHERS eBooks
  77. Preclinical Studies of PROTACs in Hematological Malignancies
    Ota Fuchs, Radka Bokorová · 2021 · Cardiovascular & Haematological Disorders - Drug Targets
  78. STOP‐AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease
    Sara K. Quinney, Murugesh Kandasamy, Adrian L. Oblak, Kristen D. Onos, Mike Sasner, Anna K. Greenwood, Kara Woo, Stacey J. Sukoff Rizzo, Paul R. Territo · 2023 · Alzheimer s & Dementia
  79. Estimating protein–ligand interactions with geometric deep learning and mixture density models
    Yogesh Kalakoti, Swaraj Gawande, Durai Sundar · 2024 · Journal of Biosciences
  80. Microfluidic technologies for protein crystallography: advances and applications
    Masatoshi Maeki, Akihiko Ishida, Manabu Tokeshi · 2025 · Analytical Sciences
  81. Virtual Libraries for Docking Methods: Guidelines for the Selection and the Preparation
    Asma Sellami, Manon F. Réau, Florent Langenfeld, Nathalie Lagarde, Matthieu Montès · 2021 · Elsevier eBooks
  82. Emerging Role of Structural and Systems Biology in Anticancer Therapeutics
    Manzar Alam, Ahmad Abu Turab Naqvi, Md. Imtaiyaz Hassan · 2022 · Springer eBooks
  83. Hit and Lead Identification from Fragments
    Michael P. Mazanetz, Richard Law, Mark A. Whittaker · 2013
  84. NMR Studies of Protein–Small Molecule Interactions for Drug Discovery
    Daniel F. Wyss, Edward R. Zartler · 2020
  85. Polycyclic Tetramate Macrolactams and Their Potential as Anticancer Agents
    Alexandria Montavon, M. Raquel Marchán-Rivadeneira, Yong Han · 2024 · Organics
  86. Recent Trends in Development of Novel Therapeutics for Modulation of 14-3-3 Protein-Protein Interactions in Diseases
    Arshia Nazir · 2024 · Protein and Peptide Letters
  87. Macrocyclization of backbone N -methylated peptides by a prolyl oligopeptidase with a distinctive substrate recognition mechanism
    Emmanuel Matabaro, Haigang Song, Lukas Sonderegger, Fabio Gherlone, Andrew M. Giltrap, Sam Liver, Alvar D. Gossert, Markus Künzler, James H. Naismith · 2025 · Chemical Science
  88. Combining bioinformatics, chemoinformatics and experimental approaches to design chemical probes: Applications in the field of blood coagulation
    Bruno O. Villoutreix · 2016 · Annales Pharmaceutiques Françaises
  89. Peptidomimetics of α‐Helical and β‐Strand Protein Binding Epitopes
    Nina Bionda, Rudi Fasan · 2015 · Wiley eBooks
  90. In Vitro Investigation on Therapeutic Potential of Juglone, a Naphthoquinone from Walnuts against Pancreatic Cancer
    Namrata Karki · 2016
  91. M1-NP1 interfering-peptide inhibits cancer cell proliferation and migration by targeting the transcription factor FOXM1
    Chaozhu Pei, Ziwu Xu, Min Ouyang, Huitong Bu, Zhenyu Zou, Yuting Ma, Zhengqing Zhu, Yan Chen, Li Yu, Mingmin Huang et al. · 2025 · Journal of Pharmaceutical Analysis
  92. Step IIIb: The Drug-Like Chemical Diversity Pool: Diverse and Targeted Compound Collections
    Pierfausto Seneci · 2018 · Elsevier eBooks
  93. From Rings to Remedies: Investigating the Structure-Activity Relationship of Macrocyclic Anticancer Agents
    Sadia Rani, Samina Aslam, Ali Irfan, Emilio Mateev, Sami A. Al‐Hussain, Magdi E. A. Zaki · 2024 · IntechOpen eBooks
  94. Preclinical Research in Drug Discovery
    Roberto Antolović, Dubravko Jelić, Darko Marković · 2024 · Clinical gastroenterology
  95. Theoretical Considerations of the Application of DNA‐Encoded Libraries to Drug Discovery
    Charles A. Wartchow · 2014
  96. A Structural View on Druggability
    Ursula Egner, Roman Christian Hillig · 2020 · Wiley eBooks
  97. A Leap into the Chemical Space of Protein–Protein Interaction Inhibitors
    Bruno O. Villoutreix, Céline M. Labbé, David Lagorce, Guillaume Laconde, Olivier Spérandio · 2013 · Methods and principles in medicinal chemistry
  98. Applications of NMR in Fragment-Based Drug Design
    Isabelle Krimm · 2015 · Royal Society of Chemistry eBooks
  99. Relações quantitativas entre a estrutura e atividade para uma série de antichagásicos derivados do fenarimol
    Anacleto Silva de Souza · 2015
  100. Computational Methods for Prediction of Protein-Protein Interactions
    Sneha Rai, Sonika Bhatnagar · 2017 · IGI Global eBooks